BlackRock’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,565,663
| Closed | -$11.9M | – | 5079 |
|
|
2019
Q1 | $11.9M | Sell |
2,565,663
-114,935
| -4% | -$531K | ﹤0.01% | 3015 |
|
|
2018
Q4 | $9.38M | Sell |
2,680,598
-30,189
| -1% | -$106K | ﹤0.01% | 3107 |
|
|
2018
Q3 | $27.3M | Buy |
2,710,787
+73,282
| +3% | +$739K | ﹤0.01% | 2686 |
|
|
2018
Q2 | $19.1M | Buy |
2,637,505
+193,740
| +8% | +$1.4M | ﹤0.01% | 2867 |
|
|
2018
Q1 | $14.8M | Sell |
2,443,765
-118,680
| -5% | -$717K | ﹤0.01% | 2904 |
|
|
2017
Q4 | $24.6M | Sell |
2,562,445
-159,043
| -6% | -$1.53M | ﹤0.01% | 2654 |
|
|
2017
Q3 | $24.2M | Buy |
2,721,488
+71,819
| +3% | +$638K | ﹤0.01% | 2664 |
|
|
2017
Q2 | $33.5M | Buy |
2,649,669
+16,511
| +0.6% | +$209K | ﹤0.01% | 2461 |
|
|
2017
Q1 | $27.7M | Buy |
2,633,158
+2,595,568
| +6,905% | +$27.3M | ﹤0.01% | 2553 |
|
|
2016
Q4 | $347K | Sell |
37,590
-18,085
| -32% | -$167K | ﹤0.01% | 1806 |
|
|
2016
Q3 | $656K | Buy |
55,675
+10,570
| +23% | +$125K | ﹤0.01% | 1615 |
|
|
2016
Q2 | $584K | Buy |
45,105
+2,187
| +5% | +$28.3K | ﹤0.01% | 1583 |
|
|
2016
Q1 | $687K | Sell |
42,918
-12,354
| -22% | -$198K | ﹤0.01% | 1441 |
|
|
2015
Q4 | $1.58M | Buy |
55,272
+54,852
| +13,060% | +$1.57M | ﹤0.01% | 1153 |
|
|
2015
Q3 | $12K | Hold |
420
| – | – | ﹤0.01% | 2633 |
|
|
2015
Q2 | $15K | Sell |
420
-62
| -13% | -$2.21K | ﹤0.01% | 2516 |
|
|
2015
Q1 | $14K | Hold |
482
| – | – | ﹤0.01% | 2524 |
|
|
2014
Q4 | $10K | Hold |
482
| – | – | ﹤0.01% | 2765 |
|
|
2014
Q3 | $9K | Hold |
482
| – | – | ﹤0.01% | 2779 |
|
|
2014
Q2 | $8K | Buy |
482
+104
| +28% | +$1.73K | ﹤0.01% | 2914 |
|
|
2014
Q1 | $8K | Hold |
378
| – | – | ﹤0.01% | 2858 |
|
|
2013
Q4 | $5K | Hold |
378
| – | – | ﹤0.01% | 3025 |
|
|
2013
Q3 | $4K | Hold |
378
| – | – | ﹤0.01% | 3028 |
|
|
2013
Q2 | $2K | Buy |
+378
| New | +$2K | ﹤0.01% | 3094 |
|